Contac Allergy Tablet
NDC Package 71179-010-85
Package Information
Contac Allergy (loratadine) tablets is usestemporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • itchy, watery eyes • sneezing • itching of the nose or throat. This formulation utilizes a tablet delivery system. Marketed by Vespyr Brands Llc, this product is identified by NDC 71179-010 and is authorized under FDA application ANDA208314.
Identification & Billing
- RxCUI: 311372 - loratadine 10 MG 24HR Oral Tablet
- RxCUI: 311372 - loratadine 10 MG Oral Tablet
- RxCUI: 311372 - loratadine 10 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71179 - Vespyr Brands Llc
- 71179-010 - Contac Allergy
- 71179-010-85 - 1 BOTTLE in 1 CARTON / 150 TABLET in 1 BOTTLE
- 71179-010 - Contac Allergy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71179-010). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71179-010-85 identifies a specific commercial package of 1 bottle in 1 carton / 150 tablet in 1 bottle of Contac Allergy, a human over the counter drug labeled by Vespyr Brands Llc. This tablet is formulated for oral use and contains loratadine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vespyr Brands Llc on February 01, 2026. The current certification is valid through December 31, 2027.
How is this Vespyr Brands Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71179001085. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.